参考文献/References:
[1] Thompson A, Steinbeis N. Sensitive periods in executive function development[J]. Curr Opin Behav Sci, 2020, 36: 98-105.
[2] Ferguson HJ, Brunsdon V, Bradford E. The developmental trajectories of executive function from adolescence to old age[J]. Sci Rep, 2021, 11(1): 1382.
[3] Bianchi L, Macdonald JH.The mechanism of the brain and the function of the frontal lobes[Z],1922.
[4] Miller EK, Cohen JD. An integrative theory of prefrontal cortex function[J]. Annu Rev Neurosci, 2001, 24: 167-202.
[5] Ardila A, Bernal B, Rosselli M. Executive functions brain system: an activation likelihood estimation meta-analytic study[J]. Arch Clin Neuropsychol, 2018, 33(4): 379-405.
[6] Veldsman M, Werden E, Egorova N, et al. Microstructural degeneration and cerebrovascular risk burden underlying executive dysfunction after stroke[J]. Sci Rep, 2020, 10(1): 17911.
[7] Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome[J]. Brain, 1997, 23(1/2): 1581.
[8] Ahmadian N, Van BK, Van Zandvoort M, et al. The cerebellar cognitive affective syndrome-a meta-analysis[J]. Cerebellum, 2019, 18(5): 941-950.
[9] Buhrmann A, Brands A. Van der grond J, et al. Cerebellar grey matter volume in older persons is associated with worse cognitive functioning[J].Cerebellum, 2021, 20(1): 9-20.
[10] Romine CB, Lee D, Wolfe ME, et al. Wisconsin card sorting test with children: a meta-analytic study of sensitivity and specificity[J]. Arch Clin Neuropsychol, 2004, 19(8): 1027-1041.
[11] Scarpina F, Tagini S.The stroop color and Word test[Z],2017:28446889.
[12] Crowe SF. The differential contribution of mental tracking,cognitive flexibility,visual search,and motor speed to performance on parts A and B of the Trail Making Test[J]. J Clin Psychol, 1998, 54(5): 1097-4679.
[13] De Paula JJ, Paiva G, Costa DS. Use of a modified version of the switching verbal fluency test for the assessment of cognitive flexibility[J]. Dement Neuropsychol, 2015, 9(3): 258-264.
[14] Patel K, Srivastava S, Kushwah S, et al. Perspectives on the role of APOE4 as a therapeutic target for alzheimer's disease[J]. J Alzheimers Dis Rep, 2021, 5(1): 899-910.
[15] Li W, Qiu Q, Sun L, et al. Short-term adverse effects of the apolipoprotein E ε4 allele over language function and executive function in healthy older adults[J]. Neuropsychiatr Dis Treat, 2019, 15(15): 1855-1861.
[16] Prussien KV, Compas BE, Siciliano RE, et al. Cerebral hemodynamics and executive function in sickle cell anemia[J]. Stroke, 2021, 52(5): 1830-1834.
[17] Dao E, Tam R, Hsiung GR, et al. Exploring the contribution of myelin content in normal appearing white matter to cognitive outcomes in cerebral small vessel disease[J]. J Alzheimers Dis, 2021, 80(1): 91-101.
[18] Hermann P, Romero C, Schmidt C, et al. CSF biomarkers and neuropsychological profiles in patients with cerebral small-vessel disease[J]. PLoS One, 2014, 9(8): e105000.
[19] Pappas C, Small BJ, Andel R, et al. Blood glucose levels May exacerbate executive function deficits in older adults with cognitive impairment[J]. J Alzheimers Dis, 2019, 67(1): 81-89.
[20] Dlugaj M, Winkler A, Weimar C, et al. Heinz nixdorf recall study investigative group. Anemia and mild cognitive impairment in the German general population[J].J Alzheimers Dis, 2016, 49(4): 1031-1042.
[21] Li Q, Yang Y, Reis C, et al. Cerebral small vessel disease[J]. Cell Transplant, 2018, 27(12): 1711-1722.
[22] Pinter D, Enzinger C, Fazekas F. Cerebral small vessel disease, cognitive reserve and cognitive dysfunction[J]. J Neurol, 2015, 262(11): 2411-2419.
[23] Yang F, Bal SS, Lee JF, et al. White matter differences in networks in elders with mild cognitive impairment and alzheimer's disease[J]. Brain Connect, 2021, 11(3): 180-188.
[24] Chen P, Ratcliff G, Belle SH, et al. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented[J]. Neurology, 2000, 55(12): 1847-1853.
[25] Lacerda IB, Santos RL, Belfort T, et al. Domains of awareness in Alzheimer's disease: The influence of executive function[J]. Int J Geriatr Psychiatry, 2021, 36(6): 926-934.
[26] Loftus AM, Gasson N, Lopez N, et al. Cognitive reserve, executive function, and memory in parkinson's disease[J]. Brain Sci, 2021, 11(8): 992.
[27] Pelicioni Phs MJ, Marked ED, Falls in People With Parkinson's Disease. Braz J Phys Ther[J]. doi:10.1016/j.bjpt, 2020, 25(4): 437-443.
[28] Patel A, Chong DJ. Obstructive sleep apnea: cognitive outcomes[J]. Clin Geriatr Med, 2021, 37(3): 457-467.
[29] Leng Y, Mcevoy CT, Allen IE, et al. Association of Sleep-Disordered breathing with cognitive function and risk of cognitive impairment: a systematic review and meta-analysis[J]. JAMA Neurol, 2017, 74(10): 1237-1245.
[30] Chen MH, Liu YL, Kuo HW, et al. Neurofilament light chain is a novel biomarker for major depression and related executive dysfunction[J]. Int J Neuropsychopharmacol, 2022, 25(2): 99-105.
[31] Ramos-Henderson M, Ledezma-Dámes A, López N, et al. Executive functions and functional impairment in Latin seniors suffering from depression[J]. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn, 2021, 28(4): 543-558.
[32] Naef N, Schlosser L, Brugger P, et al. Brain volumes in adults with congenital heart disease correlate with executive function abilities[J]. Brain Imaging Behav, 2021, 15(5): 2308-2316.
[33] American Psychiatric Association.Diagnostic and statistical manual of mental disorders[Z].5th ed,2013.
[34] Gj S, Tseng WL, Chiu YN, et al. Executive functions in youths with autism spectrum disorder and their unaffected siblings[J]. Psychol Med, 2021, 51(15): 2571-2580.
[35] Yuan W, Ran M, Song HQ, et al. Remote ischemic conditioning May improve outcomes of patients with cerebral Small-Vessel disease[J]. Stroke, 2017, 48(11): 3064-3072.
[36] Xu R, He Q, Wang Y, et al.Therapeutic potential of remote ischemic conditioning in vascular cognitive impairment[Z],2021:34413726.
[37] Goodwill AM, Campbell S, Simpson SJ, et al. Vitamin D status is associated with executive function a decade later: Data from the Women's Healthy Ageing Project[J]. Maturitas, 2018, 107: 56-62.